Is MoonLake Immunotherapeutics (MLTX) a Buy, Sell, or Hold?
MoonLake Immunotherapeutics
NASDAQ:MLTX
$19.52 USD
-$0.89 (-4.36%)
- Volume
- 1.09M
- Average Volume
- 1.09M
- Market Capitalization
- $1.61B
- P/E Ratio
- -5.03
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $62.75
- Year Low
- $5.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.60
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
12
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
26
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 5.2M
MLTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
MLTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-07-09 | S-Sale | 20.01 | 2026-07-13 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 20.02 | 2026-07-13 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-07-01 | S-Sale | 20.03 | 2026-07-02 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-06-22 | S-Sale | 22.04 | 2026-06-23 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2026-06-17 | A-Award | 19.19 | 2026-06-22 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-06-17 | S-Sale | 19.68 | 2026-06-18 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-06-18 | S-Sale | 19.6 | 2026-06-18 |
| Phillips Andrew John | director | 2026-06-17 | A-Award | 19.19 | 2026-06-18 |
| Loy Spike | director | 2026-06-17 | A-Award | 19.19 | 2026-06-18 |
| Moukheibir Catherine | director | 2026-06-17 | A-Award | 19.19 | 2026-06-18 |
| Xavier Ramnik | director | 2026-06-17 | A-Award | 19.19 | 2026-06-18 |
| Reich Kristian | officer: Chief Scientific Officer | 2026-06-15 | S-Sale | 18.89 | 2026-06-17 |
| Reich Kristian | officer: Chief Scientific Officer | 2026-06-16 | S-Sale | 18.7 | 2026-06-17 |
| Reich Kristian | officer: Chief Scientific Officer | 2026-06-17 | S-Sale | 19.43 | 2026-06-17 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-05-11 | S-Sale | 20.02 | 2026-05-13 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-04-14 | S-Sale | 19.56 | 2026-04-16 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-04-10 | S-Sale | 18.41 | 2026-04-14 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-04-13 | S-Sale | 18.23 | 2026-04-14 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-04-09 | S-Sale | 18.94 | 2026-04-10 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-04-10 | S-Sale | 19.51 | 2026-04-10 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2026-03-31 | S-Sale | 16.79 | 2026-04-02 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2026-03-31 | S-Sale | 16.79 | 2026-04-02 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2026-03-31 | S-Sale | 16.79 | 2026-04-02 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2026-01-07 | A-Award | 0 | 2026-01-09 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2026-01-07 | A-Award | 11.29 | 2026-01-09 |
| Reich Kristian | officer: Chief Scientific Officer | 2026-01-07 | A-Award | 11.29 | 2026-01-09 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2025-12-19 | D-Return | 0 | 2025-12-22 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-12-19 | D-Return | 0 | 2025-12-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-22 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-12-19 | D-Return | 0 | 2025-12-22 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-12-08 | S-Sale | 15.08 | 2025-12-10 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-12-09 | S-Sale | 14.49 | 2025-12-10 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-12-08 | S-Sale | 15.08 | 2025-12-10 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-12-09 | S-Sale | 14.43 | 2025-12-10 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2025-10-08 | P-Purchase | 9.09 | 2025-10-09 |
| Chen Bihua | other: Former 10% Owner | 2025-09-29 | S-Sale | 9.38 | 2025-10-01 |
| Chen Bihua | other: Former 10% Owner | 2025-09-29 | S-Sale | 8.4 | 2025-10-01 |
| Chen Bihua | other: Former 10% Owner | 2025-09-29 | S-Sale | 7.58 | 2025-10-01 |
| Chen Bihua | other: Former 10% Owner | 2025-09-29 | S-Sale | 6.61 | 2025-10-01 |
| Chen Bihua | other: Former 10% Owner | 2025-09-30 | S-Sale | 6.96 | 2025-10-01 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-09-02 | C-Conversion | 0 | 2025-09-04 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-09-02 | D-Return | 0 | 2025-09-04 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-01-20 | C-Conversion | 0 | 2025-09-04 |
| Moukheibir Catherine | director | 2025-07-03 | M-Exempt | 0 | 2025-07-07 |
| Moukheibir Catherine | director | 2025-07-03 | M-Exempt | 12.25 | 2025-07-07 |
| Moukheibir Catherine | director | 2025-07-03 | S-Sale | 48.79 | 2025-07-07 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Sturge Simon | director | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Loy Spike | director | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Xavier Ramnik | director | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Moukheibir Catherine | director | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Phillips Andrew John | director | 2025-06-05 | A-Award | 48.83 | 2025-06-09 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2025-02-27 | A-Award | 0 | 2025-03-03 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-02-27 | A-Award | 41.77 | 2025-03-03 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2025-02-27 | A-Award | 0 | 2025-03-03 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-01-20 | C-Conversion | 0 | 2025-01-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-01-20 | D-Return | 0 | 2025-01-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2025-01-20 | C-Conversion | 0 | 2025-01-22 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2024-10-04 | S-Sale | 50.0016 | 2024-10-08 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2024-10-04 | S-Sale | 50.0016 | 2024-10-08 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2024-10-04 | S-Sale | 50.0016 | 2024-10-08 |
| Sturge Simon | director | 2024-10-04 | S-Sale | 53.72 | 2024-10-08 |
| BVF PARTNERS L P/IL | director, 10 percent owner: | 2024-06-06 | A-Award | 42.44 | 2024-06-10 |
| Moukheibir Catherine | director | 2024-06-06 | A-Award | 42.44 | 2024-06-07 |
| Phillips Andrew John | director | 2024-06-06 | A-Award | 42.44 | 2024-06-07 |
| Xavier Ramnik | director | 2024-06-06 | A-Award | 42.44 | 2024-06-07 |
| Sturge Simon | director | 2024-06-06 | A-Award | 42.44 | 2024-06-07 |
| Loy Spike | director | 2024-06-06 | A-Award | 42.44 | 2024-06-07 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-27 | S-Sale | 55 | 2024-02-29 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-28 | S-Sale | 55 | 2024-02-29 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-29 | S-Sale | 55.89 | 2024-02-29 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-27 | S-Sale | 55 | 2024-02-29 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-28 | S-Sale | 55 | 2024-02-29 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-27 | S-Sale | 55 | 2024-02-29 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-28 | S-Sale | 55 | 2024-02-29 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-21 | S-Sale | 55.27 | 2024-02-23 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-20 | S-Sale | 57.45 | 2024-02-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-21 | S-Sale | 55.31 | 2024-02-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-20 | S-Sale | 57.43 | 2024-02-22 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-21 | S-Sale | 55.3 | 2024-02-22 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-15 | S-Sale | 60.18 | 2024-02-20 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-16 | S-Sale | 60.15 | 2024-02-20 |
| Santos da Silva Jorge | director, officer: Chief Executive Officer | 2024-02-20 | S-Sale | 57.44 | 2024-02-20 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-14 | S-Sale | 62.42 | 2024-02-16 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-15 | S-Sale | 60.17 | 2024-02-16 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-16 | S-Sale | 60.15 | 2024-02-16 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-14 | S-Sale | 62.43 | 2024-02-16 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-15 | S-Sale | 60.16 | 2024-02-16 |
| Reich Kristian | officer: Chief Scientific Officer | 2024-02-16 | S-Sale | 60.15 | 2024-02-16 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2023-12-19 | S-Sale | 59.22 | 2023-12-21 |
| Bodenstedt Matthias | officer: Chief Financial Officer | 2023-12-20 | S-Sale | 58.34 | 2023-12-21 |
| Chen Bihua | 10 percent owner | 2023-10-05 | P-Purchase | 59.8973 | 2023-10-10 |
| Chen Bihua | 10 percent owner | 2023-10-04 | P-Purchase | 57.3188 | 2023-10-04 |
| Chen Bihua | 10 percent owner | 2023-10-03 | P-Purchase | 57.252 | 2023-10-04 |
| Chen Bihua | 10 percent owner | 2023-10-02 | P-Purchase | 57.37 | 2023-10-04 |